5-MeO-MPMI (also known as 5-Methoxy-N-methyl-(αN-trimethylene)tryptamine) is a tryptamine derivative that is a psychedelic drug. It was first developed by the team led by JE Macor in 1992 and subsequently investigated by the team led by David Nichols from Purdue University in the late 1990s.
This page contains content from the copyrighted Wikipedia article "5-MeO-MPMI"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
